Does BUSERELIN Cause Ovarian hyperstimulation syndrome? 14 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Ovarian hyperstimulation syndrome have been filed in association with BUSERELIN. This represents 20.6% of all adverse event reports for BUSERELIN.
14
Reports of Ovarian hyperstimulation syndrome with BUSERELIN
20.6%
of all BUSERELIN reports
0
Deaths
12
Hospitalizations
How Dangerous Is Ovarian hyperstimulation syndrome From BUSERELIN?
Of the 14 reports, 12 (85.7%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Ovarian hyperstimulation syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUSERELIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does BUSERELIN Cause?
Alanine aminotransferase increased (12)
Aspartate aminotransferase increased (12)
Blood creatine phosphokinase increased (12)
Blood lactate dehydrogenase increased (12)
Gamma-glutamyltransferase increased (12)
Muscular weakness (12)
Product prescribing error (12)
Pyrexia (12)
Abdominal distension (5)
Ascites (5)
What Other Drugs Cause Ovarian hyperstimulation syndrome?
CHORIOGONADOTROPIN ALFA (1,016)
FOLLITROPIN (718)
GANIRELIX (672)
TRIPTORELIN (356)
PROGESTERONE (293)
MENOTROPINS (238)
LUTROPIN ALFA (194)
GONADOTROPHIN, CHORIONIC (173)
FOLLITROPIN BETA (163)
FOLLITROPIN ALFA (138)